Peter Sölkner
Director/Board Member at OXFORD BIOMEDICA PLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stuart Paynter | M | 52 | 7 years | |
| Natalie Walter | F | 50 | 5 years | |
| Catherine Moukheibir | F | 64 | 3 years | |
| Matthew Treagus | M | - | 3 years | |
| Leone Patterson | F | 61 | 1 years | |
| Frank Mathias | M | 62 | 1 years | |
| Thomas Otto | M | - |
Vetter Pharma-Fertigung Verwaltungs GmbH
 Vetter Pharma-Fertigung Verwaltungs GmbH Miscellaneous Commercial ServicesCommercial Services Vetter Pharma-Fertigung Verwaltungs GmbH operates as a holding company with interests in providing manufacturing support services. The company is headquartered in Ravensburg. Germany.
Vetter Pharma-Fertigung GmbH & Co. KG
 Vetter Pharma-Fertigung GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services For more than 25 years, Vetter Pharma-Fertigung has been synonymous with high quality aseptically pre-filled application systems. As a strategic partner, the company supports clients from the pharmaceutical and biotechnology industries in every phase of production, from product development through to successful product launches and commercial manufacturing. The firm is an independent company without any pharmaceutical products on the market. This means it can guarantee its partners absolute loyalty - as a conflict of interests is impossible right from the start. The company is an independent international specialist in the aseptic filling of syringes, cartridges and vials. Based in Ravensburg, Germany, Vetter also produces its own injection systems, such as the Vetter Lyo-Ject® dual-chamber syringe. The company employs about 1,900 people world-wide and holds nearly 140 patents. Vetter boasts longstanding experience in handling client products and processes approved by the FDA, the EMEA and other authorities. Vetter Development Service provides support for its pharmaceutical and biotech clients in the early stages of development, from clinical phases and regulatory approval to worldwide product launch. Vetter Commercial Manufacturing handles the entire production process, from compounding and aseptic filling to the final packaging of a product. Vetter Solutions' patented application systems enable clients to compete more effectively throughout the world. | 29 years |
| Dame Davies | M | 73 | 3 years | |
| Axel Herberg | M | 66 |
Vetter Pharma-Fertigung GmbH & Co. KG
Vetter Pharma-Fertigung GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services For more than 25 years, Vetter Pharma-Fertigung has been synonymous with high quality aseptically pre-filled application systems. As a strategic partner, the company supports clients from the pharmaceutical and biotechnology industries in every phase of production, from product development through to successful product launches and commercial manufacturing. The firm is an independent company without any pharmaceutical products on the market. This means it can guarantee its partners absolute loyalty - as a conflict of interests is impossible right from the start. The company is an independent international specialist in the aseptic filling of syringes, cartridges and vials. Based in Ravensburg, Germany, Vetter also produces its own injection systems, such as the Vetter Lyo-Ject® dual-chamber syringe. The company employs about 1,900 people world-wide and holds nearly 140 patents. Vetter boasts longstanding experience in handling client products and processes approved by the FDA, the EMEA and other authorities. Vetter Development Service provides support for its pharmaceutical and biotech clients in the early stages of development, from clinical phases and regulatory approval to worldwide product launch. Vetter Commercial Manufacturing handles the entire production process, from compounding and aseptic filling to the final packaging of a product. Vetter Solutions' patented application systems enable clients to compete more effectively throughout the world. | - |
| Heather Elizabeth Preston | M | 58 | 6 years | |
| Stuart Henderson | M | 66 | 8 years | |
| Frederic Roch Doliveux | M | 68 | 4 years | |
| Namrata Patel | F | - | 2 years | |
| Kyriacos Mitrophanous | M | - | 27 years | |
| Robert Ghenchev | M | 41 | 5 years | |
| Sebastien Ribault | M | - | 2 years | |
| Sophia Bolhassan | F | - | 3 years | |
| James Miskin | M | - | 24 years | |
| Mair Faibish | M | 64 |
The Trustees of Columbia University in The City of New York
| 23 years |
| Oskar Gold | M | - |
Vetter Pharma-Fertigung GmbH & Co. KG
Vetter Pharma-Fertigung GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services For more than 25 years, Vetter Pharma-Fertigung has been synonymous with high quality aseptically pre-filled application systems. As a strategic partner, the company supports clients from the pharmaceutical and biotechnology industries in every phase of production, from product development through to successful product launches and commercial manufacturing. The firm is an independent company without any pharmaceutical products on the market. This means it can guarantee its partners absolute loyalty - as a conflict of interests is impossible right from the start. The company is an independent international specialist in the aseptic filling of syringes, cartridges and vials. Based in Ravensburg, Germany, Vetter also produces its own injection systems, such as the Vetter Lyo-Ject® dual-chamber syringe. The company employs about 1,900 people world-wide and holds nearly 140 patents. Vetter boasts longstanding experience in handling client products and processes approved by the FDA, the EMEA and other authorities. Vetter Development Service provides support for its pharmaceutical and biotech clients in the early stages of development, from clinical phases and regulatory approval to worldwide product launch. Vetter Commercial Manufacturing handles the entire production process, from compounding and aseptic filling to the final packaging of a product. Vetter Solutions' patented application systems enable clients to compete more effectively throughout the world. | - |
| Hermann Piana | M | - |
Vetter Pharma-Fertigung GmbH & Co. KG
Vetter Pharma-Fertigung GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services For more than 25 years, Vetter Pharma-Fertigung has been synonymous with high quality aseptically pre-filled application systems. As a strategic partner, the company supports clients from the pharmaceutical and biotechnology industries in every phase of production, from product development through to successful product launches and commercial manufacturing. The firm is an independent company without any pharmaceutical products on the market. This means it can guarantee its partners absolute loyalty - as a conflict of interests is impossible right from the start. The company is an independent international specialist in the aseptic filling of syringes, cartridges and vials. Based in Ravensburg, Germany, Vetter also produces its own injection systems, such as the Vetter Lyo-Ject® dual-chamber syringe. The company employs about 1,900 people world-wide and holds nearly 140 patents. Vetter boasts longstanding experience in handling client products and processes approved by the FDA, the EMEA and other authorities. Vetter Development Service provides support for its pharmaceutical and biotech clients in the early stages of development, from clinical phases and regulatory approval to worldwide product launch. Vetter Commercial Manufacturing handles the entire production process, from compounding and aseptic filling to the final packaging of a product. Vetter Solutions' patented application systems enable clients to compete more effectively throughout the world. | 20 years |
| Joachim del Boca | M | - |
Vetter Pharma-Fertigung GmbH & Co. KG
Vetter Pharma-Fertigung GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services For more than 25 years, Vetter Pharma-Fertigung has been synonymous with high quality aseptically pre-filled application systems. As a strategic partner, the company supports clients from the pharmaceutical and biotechnology industries in every phase of production, from product development through to successful product launches and commercial manufacturing. The firm is an independent company without any pharmaceutical products on the market. This means it can guarantee its partners absolute loyalty - as a conflict of interests is impossible right from the start. The company is an independent international specialist in the aseptic filling of syringes, cartridges and vials. Based in Ravensburg, Germany, Vetter also produces its own injection systems, such as the Vetter Lyo-Ject® dual-chamber syringe. The company employs about 1,900 people world-wide and holds nearly 140 patents. Vetter boasts longstanding experience in handling client products and processes approved by the FDA, the EMEA and other authorities. Vetter Development Service provides support for its pharmaceutical and biotech clients in the early stages of development, from clinical phases and regulatory approval to worldwide product launch. Vetter Commercial Manufacturing handles the entire production process, from compounding and aseptic filling to the final packaging of a product. Vetter Solutions' patented application systems enable clients to compete more effectively throughout the world. | - |
| Udo Johannes Vetter | M | 69 |
Vetter Pharma-Fertigung GmbH & Co. KG
Vetter Pharma-Fertigung GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services For more than 25 years, Vetter Pharma-Fertigung has been synonymous with high quality aseptically pre-filled application systems. As a strategic partner, the company supports clients from the pharmaceutical and biotechnology industries in every phase of production, from product development through to successful product launches and commercial manufacturing. The firm is an independent company without any pharmaceutical products on the market. This means it can guarantee its partners absolute loyalty - as a conflict of interests is impossible right from the start. The company is an independent international specialist in the aseptic filling of syringes, cartridges and vials. Based in Ravensburg, Germany, Vetter also produces its own injection systems, such as the Vetter Lyo-Ject® dual-chamber syringe. The company employs about 1,900 people world-wide and holds nearly 140 patents. Vetter boasts longstanding experience in handling client products and processes approved by the FDA, the EMEA and other authorities. Vetter Development Service provides support for its pharmaceutical and biotech clients in the early stages of development, from clinical phases and regulatory approval to worldwide product launch. Vetter Commercial Manufacturing handles the entire production process, from compounding and aseptic filling to the final packaging of a product. Vetter Solutions' patented application systems enable clients to compete more effectively throughout the world. | - |
| Robert C. Atkinson | M | 73 |
The Trustees of Columbia University in The City of New York
| 24 years |
| Michael Hayden | M | 72 | 3 years | |
| Alan Brott | M | 82 |
The Trustees of Columbia University in The City of New York
| 24 years |
| Lisa James | F | - | 8 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Yong-Han Lee | M | - |
The Trustees of Columbia University in The City of New York
| 9 years |
| Craig Cummings | M | - |
The Trustees of Columbia University in The City of New York
| 5 years |
| Peter Eliot | M | - |
The Trustees of Columbia University in The City of New York
| 3 years |
| Neal Karnovsky | M | - |
The Trustees of Columbia University in The City of New York
| 7 years |
| Gregory Fairchild | M | 61 |
The Trustees of Columbia University in The City of New York
| 5 years |
| Matthew Grossman | M | - |
The Trustees of Columbia University in The City of New York
| 5 years |
| Andreas Ronken | M | 57 |
University of Dortmund
| 6 years |
| Timothy Gildner | M | - |
The Trustees of Columbia University in The City of New York
| 1 years |
| Niels Heilmann | M | - |
The Trustees of Columbia University in The City of New York
| 5 years |
| Keith Hwang | M | - |
The Trustees of Columbia University in The City of New York
| 7 years |
| Suhit Gupta | M | - |
The Trustees of Columbia University in The City of New York
| 5 years |
| Ming Yeung Lau | M | 45 |
The Trustees of Columbia University in The City of New York
| 5 years |
| Curt LaBelle | M | 53 |
The Trustees of Columbia University in The City of New York
| 5 years |
| Hank L. Torbert | M | 52 |
The Trustees of Columbia University in The City of New York
| 3 years |
| Giovanni Monti | M | 52 |
The Trustees of Columbia University in The City of New York
| 3 years |
| Erik Norgaard | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Bennett Cohen | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| David Dobkin | M | 45 |
The Trustees of Columbia University in The City of New York
| 4 years |
| Suresh Chandra Dalai | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Xiang Fei | M | 52 |
The Trustees of Columbia University in The City of New York
| 1 years |
| Alejandro Frenkel | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Lama Kanazeh | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Robert Henry Toth | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Dicky Yordan | M | 47 |
The Trustees of Columbia University in The City of New York
| 1 years |
| Larry Manis | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Ryan Rex Gephart | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Qi Yuan Ma | M | 67 |
The Trustees of Columbia University in The City of New York
| 6 years |
| Richard Mulry | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Chetan Bagga | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Stefanie Jay | F | 45 |
The Trustees of Columbia University in The City of New York
| 4 years |
| Cairn Seale | F | 53 |
The Trustees of Columbia University in The City of New York
| 2 years |
| Xiang Liao | M | 59 |
The Trustees of Columbia University in The City of New York
| 2 years |
| Hai Tao | M | 53 |
The Trustees of Columbia University in The City of New York
| 3 years |
| Yi Zhang | F | 48 |
The Trustees of Columbia University in The City of New York
| 1 years |
| Matthew Porter | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Dan Maccarone | M | - |
The Trustees of Columbia University in The City of New York
| 1 years |
| Daniel Goldman | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Anthony Hong | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| David Meneret | M | - |
The Trustees of Columbia University in The City of New York
| 1 years |
| Camille DeLaite | F | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Fang Jian | M | - |
The Trustees of Columbia University in The City of New York
| 1 years |
| Alexander Dias | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Thomas Leggett | M | 47 |
The Trustees of Columbia University in The City of New York
| 4 years |
| Arthur Butcher | M | 53 |
The Trustees of Columbia University in The City of New York
| 2 years |
| Alex Albert | M | - |
The Trustees of Columbia University in The City of New York
| 1 years |
| James Sullivan | M | - |
The Trustees of Columbia University in The City of New York
| 3 years |
| Felix J. Park | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Philson S. Yim | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Andrew Lee Hain | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Ashish Agarwal | M | 45 |
The Trustees of Columbia University in The City of New York
| 4 years |
| Mike A. Bego | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| David E. Fife | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| James Allen Schwartz | M | 56 |
The Trustees of Columbia University in The City of New York
| 2 years |
| Ben Wang | M | 54 |
The Trustees of Columbia University in The City of New York
| 3 years |
| Ion Yadigaroglu | M | 54 |
The Trustees of Columbia University in The City of New York
| 2 years |
| Atul Varma | M | 50 |
The Trustees of Columbia University in The City of New York
| 2 years |
| Richard Safran | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Matthew B. Chaldecott | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Herbert L. Kloiber | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Benjamin Hur | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Jeffrey Neal Holtman | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Khalil Hatem Khalil Al-Salem | M | 41 |
The Trustees of Columbia University in The City of New York
| 4 years |
| Carter Reum | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Scott Weiss | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Mughith Ghiath Munir Sukhtian | M | 51 |
The Trustees of Columbia University in The City of New York
| 12 years |
| Karl Willi-Pieper | M | - |
University of Dortmund
| 3 years |
| Can Ikinci | M | - |
The Trustees of Columbia University in The City of New York
| 1 years |
| Elad Kushnir | M | - |
The Trustees of Columbia University in The City of New York
| 3 years |
| Arthur T. Williams | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Paul Weismann | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Kirby Joel Mack | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Andrew M. Wallach | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Tim Riley | M | - |
The Trustees of Columbia University in The City of New York
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 74 | 74.00% |
| United Kingdom | 18 | 18.00% |
| Germany | 8 | 8.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Peter Sölkner
- Personal Network
